Home > Insider Trading > Filing (0001181431-12-046134)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1466301	Clovis Oncology Inc.	CLVS	Pharmaceutical Preparations (2834)	900475355

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1306143	J Edward Mckinley	C/O Clovis Oncology, Inc. 2525 28Th Street, Suite 100 Boulder CO 80301		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-08-14	5,201	$15.40	290,931	No	4	P	Direct
Common Stock	Acquisiton	2012-08-15	1,000	$15.50	291,931	No	4	P	Direct
Common Stock	Acquisiton	2012-08-16	3,500	$15.66	295,431	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.32 to $15.50, inclusive. The reporting person undertakes to provide to Clovis Oncology, Inc., any security holder of Clovis Oncology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.48 to $15.50, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.42 to $15.87, inclusive.